Gufic BioSciences Ltd. share price target and research reports

Name: Latest research reports of Gufic BioSciences Ltd. authored by KamayaKya Wealth and published by - Trendlyne research reports.
Item: Gufic BioSciences Ltd.
Rating: 5
Author: KamayaKya Wealth

Latest analyst research reports with target prices and PDF download for GUFICBIO, BSE:509079 Gufic BioSciences Ltd.

Search Inside the pdf :

Gufic BioSciences Ltd.

17 Dec 2022

340.45

3.29%

Initiating Coverage

Buy: Gufic BioSciences Ltd.

KamayaKya Wealth

Going forward, we estimate a 20% CAGR till FY24 (based on non COVID-19 products), driven by doubling of capacities in the lyophilisation segment, increase in market share of niche products and new product launches coupled with geographical expansion.

Gufic BioSciences Ltd. is trading below its 50 day SMA of 367.2

Is Gufic BioSciences Ltd. worth buying?

137 Votes:

Buy 81.75%

Sell 10.22%

Hold 8.03%